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Abstract
While most chemokine receptors fail to cross the chemokine class boundary with respect to the ligands that they bind, the
human cytomegalovirus (HCMV)-encoded chemokine receptor US28 binds multiple CC-chemokines and the CX3C-
chemokine Fractalkine. US28 binding to CC-chemokines is both necessary and sufficient to induce vascular smooth muscle
cell (SMC) migration in response to HCMV infection. However, the function of Fractalkine binding to US28 is unknown. In
this report, we demonstrate that Fractalkine binding to US28 not only induces migration of macrophages but also acts to
inhibit RANTES-mediated SMC migration. Similarly, RANTES inhibits Fractalkine-mediated US28 migration in macrophages.
While US28 binding of both RANTES and Fractalkine activate FAK and ERK-1/2, RANTES signals through Ga12 and
Fractalkine through Gaq. These findings represent the first example of differential chemotactic signaling via a multiple
chemokine family binding receptor that results in migration of two different cell types. Additionally, the demonstration that
US28-mediated chemotaxis is both ligand-specific and cell type–specific has important implications in the role of US28 in
HCMV pathogenesis.
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Introduction
All b and c-herpesviruses encode molecules with the potential to
modulate the host immune response, including chemokines and/
or chemokine receptor homologs. The b-herpesvirus human
cytomegalovirus (HCMV) encodes a CXC-chemokine (UL146),
a potential CC-chemokine (UL128), and four potential chemokine
receptors (US27, US28, UL33 and UL78) with the most
characterized being US28 [1–4]. Chemokines are small, inducible
cytokines that have critical roles in the induction and promotion of
cellular migration and activation upon binding 7-transmembrane
spanning G-protein coupled receptors (GPCRs). There are four
major chemokine subfamilies that are categorized according to the
spacing of the first two conserved amino-terminal cysteine
residues: CC-, CXC-, CX3C- and XC-. Most chemokine receptors
bind a limited subset of ligands belonging to a single subfamily.
The ability to bind multiple ligands from different chemokine
subfamilies is unique to a select few receptors including the Duffy
antigen/receptor for chemokine (DARC-receptor) and the HHV-
8-encoded chemokine receptor Orf74. These receptors have been
reported to bind to both CC- and CXC-chemokines [5–7]. US28
also binds multiple ligands from different subfamilies. US28
contains homology to CC-chemokine receptors, with greatest
homology to CCR1 [8] and binds to a broad spectrum of CC-
chemokines with high affinity including: RANTES, MCP-1, MIP-
1a and MIP-1b [9]. Interestingly, US28 also binds the CX3C-
chemokine Fractalkine and with greater affinity than CC-
chemokines. Although the N-terminal 22 amino acids of US28
have been shown to be required for binding of both chemokine
classes [10], binding is not competed with saturating quantities of
selected CC-chemokines [11]. Therefore, Fractalkine is predicted
to bind unique regions of US28 compared to the CC-chemokines.
Indeed, recent mutagenesis studies of the US28 N-terminus
revealed that the phenylalanine residue at position 14 of US28 is
important for binding of CC chemokines but is dispensable for
Fractalkine binding, while mutation of tyrosine 16 negatively
effects binding of both classes of chemokines [12].
Binding of chemokines to their respective receptors stimulates
the cell type-dependent activation of a plethora of cellular
signaling pathways specific to the chemokine/receptor pair. The
CC-chemokines are known to be potent stimulators of cellular
activation through US28. For example, in 293 cells, RANTES
binding to US28 activates ERK-1/2 pathways through the G-
proteins Gai1 and Ga16 [13]. We have previously demonstrated
that US28-mediated SMC migration is ligand-dependent requir-
ing either exogenously added RANTES or endogenously ex-
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pressed MCP-1 [14]. This migratory process is not blocked by
treatment with pertussis toxin (PTX), a Gai/o G-protein inhibitor,
suggesting that other G-proteins are involved in this event [14].
Subsequent studies revealed that US28 couples with Ga12/13,
promoting SMC migration and ligand-dependent signaling
through the small G-protein RhoA [15]. US28 mediated SMC
migration is also sensitive to treatment with protein tyrosine kinase
(PTK) inhibitors, and the PTKs focal adhesion kinase (FAK) and
Src are activated in US28 expressing cells upon RANTES binding
[16]. Dominant negative inhibitory FAK molecules blocked US28
induced SMC migration suggesting that FAK activation is critical
for US28 mediated SMC motility [16].
Although US28 binding to CC-chemokines leads to the
activation of a multitude of cellular signaling pathways, the only
activities associated with US28 binding to Fractalkine involve the
modulation of constitutive signaling activity [17–19]. Treatment of
US28 expressing cells with Fractalkine or the US28 synthetic
inverse agonist VUF2274 leads to substantial decreases in the
ability of US28 to promote the Gaq/11 dependent constitutive
activation of phospholipase-C (PLC) and NF-kB, whereas MCP-1
and RANTES have only negligible effects on constitutive signaling
levels [10,18]. Additionally, Fractalkine treatment of US28
expressing HEK293A cells reduces constitutive US28 phosphor-
ylation [19] and steady state levels of surface US28, but has little
influence on the rapid endocytosis observed in HeLa cells [17].
The ability of US28 to efficiently bind ligands from multiple
chemokine subfamilies coupled with the vastly different signaling
responses elicited by divergent ligands is intriguing and suggests
that US28 signaling is not only ligand and cell-type dependent, but
also ligand-specific.
In the current study, we investigate the signaling potential of
US28 upon stimulation with CC-chemokines compared to the
CX3C-chemokine Fractalkine. We demonstrate that Fractalkine
binding to US28 inhibits the ability of CC-chemokines to induce
SMC migration. RANTES, MCP-1, and Fractalkine binding to
US28 induced similar levels of FAK activation in fibroblasts.
Overexpression studies indicate that RANTES-mediated stimula-
tion of FAK occurs via a Ga12-dependent mechanism while
Fractalkine utlilzes Gaq. In contrast to SMC, when US28 is
expressed in macrophages, Fractalkine stimulation produces
robust migration These results suggest that US28-signaling is
ligand-specific and cell type-specific, and that RANTES and
Fractalkine promote differential G-protein coupling leading to the
activation of alternative signaling pathways depending on the cell-
type and the complement of endogenously expressed G-proteins.
Results
Ligand-Specific US28 Mediated Smooth Muscle Cell
Migration
The unique ability of US28 to bind both CC- and CX3C-
chemokine ligands raises the question of whether US28 signaling is
not only ligand-dependent, but also ligand-specific [9,13,20,21].
To determine whether US28 signaling and SMC migration are
ligand-specific, we performed SMC migration and signaling assays
on US28 adenovirus expressing primary rat SMC in the presence
of RANTES or Fractalkine. In this assay, RANTES readily
induced US28-mediated SMC migration, however, increasing
concentrations of Fractalkine failed to stimulate cellular motility
above Ad-tet-transactivator (Trans) infected and RANTES
stimulated controls, indicating that not all US28 ligands evoke
the same functional response (Figure 1A). Visual analysis of the
cells prior to and following the migration assay indicated that the
lack of migration was not due to overt cell death mediated by
US28 expression and subsequent treatment with Fractalkine (data
not shown). A competition assay was performed to determine
whether Fractalkine inhibits the ability of RANTES to induce
SMC migration. In these experiments, RANTES alone promoted
SMC migration, as expected. However, Fractalkine, at concen-
trations as low as 10ng/ml, was sufficient to block RANTES-
mediated SMC migration (Figure 1B) suggesting that Fractalkine is
a competitive inhibitor to CC-chemokine induced SMC migra-
tion.
Since RANTES but not Fractalkine caused the migration of
US28 expressing SMC and since Fractalkine blocks this migration
event, we hypothesized that the difference in the ability to promote
motility occurred at the level of signaling. To determine whether
there exists a gross difference in the ability of these chemokine
receptors/ligands to modulate intracellular signaling cascades,
host transcriptional profiles were examined using DNA micro-
arrays. Interestingly, the cellular gene expression profile of US28-
expressing SMC stimulated with RANTES substantially differs
from the profile obtained upon stimulation with Fractalkine. In
fact, most of the genes that were up-regulated upon RANTES
stimulation were down-regulated by Fractalkine. Specifically,
RANTES binding to US28 induced expression of a number of
cellular genes involved in cellular migration, while Fractalkine
down-regulated many of these same genes (data not shown). These
findings indicate that there are ligand-specific differences in US28
signaling that parallel the ability of either RANTES or Fractalkine
to promote SMC migration.
Ligand-Specific Signaling Mediated by US28
To determine if the different phenotypic outcomes of RANTES
or Fractalkine binding to US28 is reflected in differences at the
level of signal transduction, we examined the ability each class of
chemokine ligand to activate FAK through binding to US28. We
have previously demonstrated that RANTES binding to US28
stimulates the activation of FAK, promoting a specific association
between phosphorylated FAK and the adaptor protein Grb2. FAK
Author Summary
Chemokines are small cytokines that are critical for
recruiting and activating the cells of the immune system
during viral infections. A number of viruses, including the
large herpes virus human cytomegalovirus (HCMV),
encode mechanisms to impede the effects of chemokines
or have gained the ability to use these molecules to their
own advantage. HCMV encodes multiple chemokine
receptors including US28, which binds two different
classes of chemokines namely the CC and CX3C families.
In this report, we demonstrate that US28 binding to a CC
chemokine elicits different responses compared to when
binding to Fractalkine, the only CX3C chemokine. RANTES
(CC chemokine) binding to US28 mediates smooth muscle
cell migration, but Fractalkine blocks this process in a
dose-dependent manner. However, Fractalkine binding to
US28 can specifically mediate the migration of macro-
phages, another important cell type during viral patho-
genesis. We explored the intracellular signaling pathways
responsible for each migration event and determined that
they differ in the G-proteins that are coupled to US28
following addition of ligand and that this occurs in a cell
type–specific manner. These results provide a new
mechanism for HCMV acceleration of vascular disease via
the specific migration of macrophages and provide the
first example of cell type–specific migration via multiple
chemokines binding to a single receptor.
US28 Ligand-Specific Migration
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is a critical mediator of focal adhesion turnover and plays
important roles in cellular adhesion and motility. As such, it
displays high basal activity levels in most cell types. For these
experiments we developed a clean inducible signaling assay using
FAK knockout mouse fibroblasts (FAK2/2) that have been
reconstituted with an adenovirus vector expressing wild-type FAK
concurrent with the addition of Ad-US28 [16]. To determine the
ability of CC-chemokines and the CX3C-chemokine Fractalkine
to promote US28 mediated activation of FAK and formation of
active Grb2/FAK complexes, FAK2/2 cells expressing US28
alone or in combination with FAK were stimulated with
RANTES, MCP-1 or Fractalkine (40ng/ml) for 0 (unstimulated),
5, 10, 15 or 30 minutes. Grb2 was immunoprecipitated and active
FAK associated with Grb2 visualized by western blotting for
Phospho-Tyr [16]. RANTES, MCP-1 and Fractalkine all
promoted US28-mediated FAK activation and formation of
Grb2/FAK complexes with similar kinetics but slightly different
magnitudes of activation (Figure 2A).
RANTES (CCL5)-induced signaling through US28 also pro-
motes pronounced actin-cytoskeletal changes in multiple cell types
[14–16]. Therefore, we also examined the ability of RANTES,
MCP-1, or Fractalkine to promote actin cytoskeletal re-arrange-
ments through US28 in FAK2/2 fibroblasts. FAK2/2 cells
infected with adenoviruses expressing US28 and FAK were
stimulated with RANTES, MCP-1, or Fractalkine (40ng/ml).
Two hours post-ligand stimulation, fixed and permeabilized cells
Figure 1. Fractalkine inhibits US28-mediated SMC migration induced by RANTES. (A) SMC migration assays were performed on cells
infected with adenovirus expressing US28-HA treated with either RANTES or Fractalkine at the indicated concentrations. Data are represented as a
percentage of unstimulated cells infected with control adenovirus transactivator only. For all conditions, n.6 from two independent experiments. (B)
SMC migration assays were performed on US28-expressing cells treated with RANTES, Fractalkine or 40ng/ml of RANTES and the indicated
concentrations of Fractalkine as a competing ligand.
doi:10.1371/journal.ppat.1000304.g001
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were incubated with antibodies directed against the Flag (US28)
and HA (FAK) epitopes, and actin visualized by staining with
Phalloidin. While RANTES, MCP-1, and Fractalkine failed to
stimulate morphological changes in the absence of US28 (data not
shown) each of the three ligands readily promoted actin
cytoskeletal re-arrangements in US28 expressing cells (Figure 2B).
Figure 2. All US28 ligands are capable of activating FAK and inducing Actin Stress Fiber Formation in reconstituted FAK2/2 cells.
(A) FAK activation was determined by Grb2/FAK co-immunoprecipitation reactions on Ad-FAK reconstituted FAK2/2 cells infected with Ad-US28
that were treated with RANTES, Fractalkine, MCP-1. Cells were harvested in modified RIPA buffer at 0 (unstimulated), 5, 10, 15, and 30 minutes post
addition of ligand. Active FAK associated with Grb2 was visualized by western blotting for phospho-FAK. (B) FAK null cells infected with Ad-US28
were reconstituted with WT FAK via adenovirus transduction. RANTES, MCP-1, or Fractalkine treated cells were fixed two hours post addition of
ligand. Cells were stained for actin with phalloidin (actin) and FAK using antibodies directed against the FAK-N’terminal HA-tag, and US28 using
antibodies directed against the N-terminal Flag epitope present on US28. All images are 606magnification.
doi:10.1371/journal.ppat.1000304.g002
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Although RANTES, MCP-1 and Fractalkine differ with respect to
their ability to promote SMC migration through US28, all are
capable of promoting FAK activation and formation of active
Grb2-FAK complexes, as well as re-organization of the actin-
cytoskeleton in fibroblasts.
Fractalkine– and RANTES–Induced FAK Activation
through US28 Require Different G-proteins
Our data indicate that although CC- and CX3C-chemokine
stimulation of US28-expressing SMC produces different migratory
phenotypes, both classes of ligands are capable of activating
common pro-migratory signaling cascades in US28-expressing
fibroblasts. We hypothesized that the disparate phenotypes seen in
US28-expressing cell types is a result of differential coupling of G-
proteins to US28. To identify the G-proteins involved in RANTES
and Fractalkine stimulated FAK activation through US28, Grb2-
FAK co-immunoprecipitation reactions were performed on lysates
from reconstituted FAK2/2 cells expressing US28. Cells were
pre-treated with the Gai/o inhibitor PTX or were left untreated
and then stimulated with either RANTES or Fractalkine (40ng/
ml) and Grb2/FAK co-immunoprecipitations were visualized by
western blotting. Pre-treatment with PTX significantly enhanced
both Fractalkine and RANTES mediated activation of FAK
through US28, suggesting that both ligands promote coupling to
G-proteins other than Gai/o family G-proteins to induce FAK
activation (Figure 3A). Interestingly, stimulation of US28 express-
ing cells with either RANTES or Fractalkine led to the PTX
resistant activation of ERK-1/2. Unlike US28 mediated FAK
activation, which was enhanced by PTX, ERK-1/2 activation was
not affected by PTX pre-treatment. Therefore, US28 mediated
activation of ERK-1/2 in reconstituted FAK2/2 cells is
independent of Gai/o family G-proteins, differing from PTX
sensitive MCP-1 and RANTES induced ERK-2 activation by
US28 observed in 293 cells [13].
We have previously determined that US28-mediated SMC
migration requires the Ga12/13-dependent activation of RhoA
[15]. Additionally, Fractalkine stimulation of US28 has been used
as an inhibitor of Gaq/11-mediated constitutive activation of
phospholipase-C (PLC) and NF-kB [10]. Since RANTES and
Fractalkine induced activation of FAK through US28 is
independent of Gai/o family G-proteins, and US28 is known to
signal through Ga12 to promote cellular migration in SMC, we
assessed the role of Ga12 in promoting RANTES and Fractalkine
mediated activation of FAK. Reconstituted FAK2/2 cells
infected with adenoviruses expressing US28 and wild-type Ga12
were stimulated with either RANTES or Fractalkine. FAK
activation was determined using Grb2-FAK co-immunoprecipita-
tion reactions as described above. Introduction of high levels of
Ga12 had little effect on the kinetics of FAK activation by
RANTES, but significantly delayed and reduced FAK activation
by Fractalkine (Figure 3B). In similar assays, over-expression of
Gaq abrogated RANTES-mediated FAK activation while Frac-
Figure 3. RANTES and Fractalkine activation of FAK is dependent on different G-proteins. (A) FAK activity in FAK 2/2 cells expressing
both US28 and wt-FAK in response to either Fractalkine or RANTES and in the presence or absence of pertussis toxin was assessed by Grb2/FAK co-
immunoprecipitation reactions. Cells were harvested in modified RIPA buffer at 0 (unstimulated), 5, 10, 15, and 30 minutes post addition of ligand.
Active FAK associated with Grb2 was visualized by western blotting for phospho-tyrosine. (B,C) The ability of Ga12 and Gaq to enhance or abrogate
RANTES and Fractalkine mediated activation of FAK through US28 was assessed by overexpressing (B) Ga12 or (C) Gaq in FAK 2/2 cells. FAK 2/2
cells infected with adenovirus expressing US28, wt-FAK and Ga12 or Gaq were stimulated with either RANTES or Fractalkine. As in (A), FAK activity
was assessed by Grb2/FAK co-immunoprecipitation reactions and active FAK associated with Grb2 was visualized by western blotting for phospho-
tyrosine. Western blots were quantified by densitomitry and fold FAK activation compared to unstimulated control is indicated below each lane.
doi:10.1371/journal.ppat.1000304.g003
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talkine mediated FAK activation was unaffected by expression of
this G-protein (Figure 3C). These data are consistent with the
observation that Fractalkine binding to US28 specifically decreases
the constitutive activation of PLC and NF-kB via a Gaq/11
dependent mechanism. This study, combined with our previous
findings, shows that US28 G-protein coupling occurs in a ligand-
specific manner wherein RANTES promotes US28 coupling to
Gai/o, Ga16 and Ga12/13, while Fractalkine promotes US28
coupling to Gaq [15].
Ligand-Specific US28 Mediated Macrophage Migration
Although Fractalkine binding to US28 fails to promote
migration in SMC, we have demonstrated that Fractalkine
stimulation causes cytoskeletal rearrangements and activates pro-
migratory signaling pathways in fibroblasts via Gaq. Given that
the endogenous complement of G-proteins differs between cell
types, we hypothesized that Fractalkine binding to US28 may
mediate migration of a second HCMV-susceptible cell type.
Fractalkine (CX3CL1), is the only known CX3C chemokine and is
unique among chemokines in that it has both membrane bound
and soluble forms. Fractalkine is both a chemotactic signal for
monocytes and sufficient for monocyte activation and adhesion
under flow conditions [22]. HCMV infection of monocyte/
macrophages is an important dissemination vehicle in vivo [23,24].
We hypothesized that the capacity of US28 to bind Fractalkine
with high affinity, in addition to CC-chemokine ligands, may play
a role in HCMV infection of monocytes. and that, in contrast to
SMC, Fractalkine stimulus may be pro-migratory in US28-
expressing monocytes. We attempted these experiments in human
monocytes in the context of HCMV infection. However, the
presence of endogenous chemokine receptors (including
RANTES-binding CCR1 and CCR5 as well as the human
fractalkine receptor CX3CR1) and endogenous chemokine ligands
in these cells made the experimental results difficult to interpret.
To compensate for technical difficulties, US28 was expressed from
an adenoviral vector in the context of a rat macrophage cell line.
We reasoned that compared to ligands produced in human
monocytes fewer endogenous rat chemokines would functionally
interact with US28 and, similarly, fewer endogenously expressed
rat chemokine receptors would signal productively in response to
stimulation with recombinant human chemokines.
Using a low temperature, low volume infection protocol, rat
macrophages were infected with adenovirus expressing US28 at
various MOI (Figure 4A). FACS analysis was used to demonstrate
US28 expression in approximately 70% of permeablized macro-
phages stained for the HA tag (Figure 4B) and that US28 is
expressed on the cell surface of adenovirus-infected macrophages.
(Figure 4C). The response of US28-expressing macrophages to
treatment with recombinant human RANTES and Fractalkine
was assessed using a quantitative in vitro migration assay. In these
assays, Fractalkine induced robust migration of US28-expressing
macrophages (Figure 4D). Statistically significant migration was
seen at very low (1ng/ml) concentrations of chemokine but not in
control cells expressing only Trans. In contrast, RANTES caused
weak migration of macrophages presumably due to low levels of
Ga12 expressed in these cells. Only the highest dose (80ng/ml) of
RANTES achieved statistical significance and this response was
not titratable with increasing chemokine as seen with Fractalkine
stimulation (Figure 4D and 4E). These results suggest that
Fractalkine is the predominant chemotactic signal in US28-
expressing macrophages. We performed chemokine competition
experiments similar to those performed in SMC (Figure 1B) to
determine whether RANTES and Fractalkine have any synergistic
effect on US28-mediated macrophage migration. Fractalkine-
dependent macrophage migration was inhibited in a dose-
dependent manner by increasing concentrations of RANTES as
a competing ligand (Figure 4F). These results show that, in direct
contrast to results seen in SMC, RANTES is a competitive
inhibitor of Fractalkine mediated macrophage migration.
To demonstrate that the US28-induced macrophage migration
specifically required US28-Fractalkine interaction, we expressed
the US28 mutant (Y16F), which is deficient in RANTES and
Fractalkine binding [12]. US28-Y16F is efficiently expressed in
adenovirus-infected macrophages (Figure 5A) and is present on the
cell surface (Figure 5B). Macrophages expressing Y16F mutant did
not migrate in response to Fractalkine (Figure 5C). Taken together
these results demonstrate that US28-expressing macrophages
respond to stimulus with recombinant human chemokine in a
ligand-specific manner. Furthermore, in contrast to the CC-
chemokine mediated migration phenotype in SMC, Fractalkine
binding to US28 produces robust migration in macrophages.
These are the first data to demonstrate a specific cellular
phenotype mediated by US28 binding to Fractalkine and the first
example of ligand-specific chemotaxis mediated by a multiple
chemokine family binding receptor.
Discussion
In the current report, by examining the functional responses,
signaling characteristics, and transcriptional profiles induced by
US28 upon binding a diversity of ligands, we demonstrate that not
only is US28-signaling ligand and cell-type dependent but also
ligand and cell type-specific. While RANTES stimulation of US28
causes robust SMC migration, Fractalkine provides an anti-
migratory signal in these cells. Similarly, RANTES but not
Fractalkine increases transcription of genes involved in SMC
migration. In contrast, Fractalkine but not RANTES provides a
strong chemotactic stimulus for US28-expressing macrophages,
and RANTES is able to competitively inhibit Fractalkine-
mediated macrophage migration. Interestingly, while these ligands
display differential signaling characteristics with respect to cellular
migration, they both are capable of activating FAK and producing
actin cytoskeletal rearrangements in fibroblasts. Importantly, we
demonstrate that these phenotypic differences can be attributed to
RANTES and Fractalkine causing differential G-protein coupling
to US28. Fractalkine induced-US28 signaling occurs in a Gaq-
dependent manner and is abrogated in the presence of Ga12 but
not by PTX. However, RANTES induced migration and signal
transduction occurrs in a Ga12 dependent manner and is blocked
by overexpression of Gaq. Ultimately, our findings indicate that
US28 binding to RANTES or Fractalkine results in differential G-
protein coupling/activation leading to unique functional conse-
quences.
While most chemokine receptors bind a limited subset of
chemokines from a single chemokine subfamily, there are three
examples of chemokine receptors that bind chemokines from
multiple subfamilies: the DARC-receptor, Orf74 of HHV-8, and
US28 [5–7,11]. To date DARC, which binds both CC- and CXC-
chemokines (CCL2, CCL5, CXCL1, and CXCL8), is the only
true chemokine sink because this receptor binds and internalizes
these ligands without inducing signaling events. Orf74 has also
been demonstrated to bind both CC- and CXC-chemokines;
however, there is a significant difference in the affinity of
individual ligands for this receptor. Despite being referred to as
an IL-8 receptor, Orf74 has greater affinity for GRO peptides
(abc) than for IL-8 [6]. In competition binding assays with IL-8,
Orf74 binding to the CC-chemokines MIP-1a, MIP-1b, MCP-1,
and RANTES was virtually undetectable, while MCP-3 and
US28 Ligand-Specific Migration
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Figure 4. Fractalkine induces US28-mediated migration of macrophages. (A) Expression of US28 was determined via western blot analysis
of total cellular lysate for the HA epitope tag. 26105 rat macrophages were infected for 72 hours with US28-HA adenovirus vector at the indicated
MOI. (B) The efficiency of adenovirus transduction was determined by FACS analysis of permeablized rat macrophages infected for 72 hours at MOI
250 with US28-HA adenovirus vector. (C) Surface expression of US28 was confirmed via FACS analysis of non-permeablized rat macrophages infected
for 72 hours at MOI 250 with US28-HA adenovirus vector. In vitro migration assays were performed on 16105 Ad-US28 and/or Ad-Trans infected rat
macrophages treated with the indicated concentrations of (D) Fractalkine or (E) RANTES. For all conditions, n$12 from four independent
experiments. Percentages are calculated relative to unstimulated macrophages infected with adenovirus transactivator (Trans). (F) Competition
migration assays were performed on Ad-US28 expressing macrophages treated with 40ng/ml of Fractalkine and the indicated concentrations of
RANTES as a competing ligand. For all conditions, n$12 from two independent experiments. Percentages are calculated relative to unstimulated
macrophages infected with Ad-Trans.
doi:10.1371/journal.ppat.1000304.g004
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Figure 5. US28-mediated migration of macrophages is ligand-dependent. (A) Expression of a chemokine binding mutant US28-Y16F-HA
was determined via western blot analysis of total cellular lysate for the HA epitope tag. A total of 26105 rat macrophages were infected for 72 hours
with US28-Y16F-HA adenovirus vector at the indicated MOI. (B) The efficiency of adenovirus transduction was determined by FACS analysis of
permeablized rat macrophages infected for 72 hours at MOI 250 with US28-Y16F-HA adenovirus vector. (C) Surface expression of US28-Y16F was
confirmed via FACS analysis of rat macrophages infected for 72 hours at MOI 100 with US28-Y16F-HA adenovirus vector. (D) In vitro migration assays
were performed on WT US28 or US28-Y16F infected rat macrophages with or without 10ng/ml Fractalkine. For all conditions, n = 8 from two
US28 Ligand-Specific Migration
PLoS Pathogens | www.plospathogens.org 8 February 2009 | Volume 5 | Issue 2 | e1000304
aminooxypentane (AOP)-RANTES display affinities in the 200nm
range. Interestingly, the structurally distinct, non-ELR containing
CXC-chemokines IP-10 and SDF-1a can displace IL-8 binding,
and function as efficient inverse agonists of Orf74 signaling at
nanomolar concentrations [6]. Although Orf74 binds to chemo-
kines from multiple chemokine subfamilies, Orf74 signaling only
occurs in the presence of ELR, and pro-inflammatory/angiogenic
chemokines, whereas the angiostatic non-ELR CXC-chemokines
function as efficient inverse agonists. Unlike Orf74, US28 binds
multiple ligands from different chemokine subfamilies with near
equal affinity [9,11], and as we demonstrate in the current report,
these distinct ligands promote cellular activation upon binding
US28. Therefore, to date, US28 is the only chemokine receptor
capable of signaling upon binding ligands from multiple
chemokine subfamilies.
We have demonstrated that both MCP-1 and RANTES
promote US28-mediated SMC migration [14]. While Fractalkine
is a known modulator of US28-induced constitutive signaling
activity [18,19], we have shown that Fractalkine does not promote
US28-mediated SMC migration and actually inhibited RANTES
mediated SMC migration. In accordance with these ligand-
specific functional responses, microarray analysis of US28-
expressing SMC stimulated with either RANTES or Fractalkine
revealed profound differences at the level of gene induction. In the
context of CMV-infection of SMC, the ability of US28 to adhere
to mobilized Fractalkine, coupled with our finding that this
chemokine reverses transcriptional activation required for cellular
migration in SMC, suggests that Fractalkine may arrest US28-
induced SMC migration and promote the subsequent adhesion of
US28 expressing SMC to the vascular endothelium. The
migration of HCMV infected and US28 expressing SMC from
the vessel media to inflammatory sites in the vessel intima and the
subsequent adhesion and accumulation of SMC in the vessel
intima may have important implications in the dissemination and
in vivo pathogenesis of HCMV, as well as in the exacerbation of
vascular disease.
In this study, we also demonstrate that Fractalkine causes robust
migration of US28-expressing macrophages, which is the first
known cellular phenotype associated with Fractalkine binding to
US28. This finding indicates that, in addition to being ligand-
dependent and ligand-specific, the function of US28 signaling is
also cell type-specific. Our finding that Fractalkine causes
migration of US28-expressing macrophages suggests a further
role for US28 in the development of vascular disease. US28 has
been shown to be expressed in HCMV-infected peripheral blood
mononuclear cells [25]. Foam cells found in atherosclerotic lesions
originate as circulating monocytes and chemokines play an
important role in the deposition of monocytes in lesions [26]. In
particular, Fractalkine expression is known to be important for the
development of atherosclerosis in mouse models of heart disease
via recruitment of macrophages into atherosclerotic plaques
[27,28]. Expression of membrane-bound Fractalkine can be
induced on endothelial cells by numerous cytokines including
IFN-c, TNF-a and IL-1, resulting in the recruitment of
inflammatory cells and contributing to chronic inflammatory
vascular diseases such as atheroscleorosis, restenosis following
angioplasty and transplant vascular sclerosis [29]. Unlike other
chemokines which are secreted as soluble molecules that must
associate with proteoglycans and other components of the
extracellular matrix to establish chemokine gradients [30],
Fractalkine is generated as a membrane bound ligand with the
chemokine domain presented at the top of the cell-bound mucin-
like stalk [29,31]. In many instances this ligand is more effective
than other ligands in promoting leukocyte activation and
migration. Our current findings suggest a secondary mechanism
for US28 in CMV-mediated vascular pathology by which
circulating CMV-positive monocytes infiltrate atherosclerotic
plaques mediated by Fractalkine binding to US28.
We demonstrate for the first time that Fractalkine is a potent
agonist capable of inducing cellular migration in macrophages and
activation of signaling pathways upon binding US28. Prior to this
study, Fractalkine had been employed as a modulator of US28-
mediated constitutive signaling activity. Some of the signaling
pathways activated by Fractalkine were similar to those activated
by the CC-chemokines. For example, RANTES, MCP-1, and
Fractalkine all display similar abilities to induce ERK-1/2, actin
cytoskeletal rearrangements and formation FAK-Grb2 complexes
in fibroblasts. Pre-treatment with PTX enhanced Fractalkine
mediated FAK activation through US28, which indicated that
Fractalkine promoted US28 coupling to G-proteins other than
Gai/o. Expression of Ga12 delayed and reduced FAK activity via
Fractalkine signaling through US28 but had no effect on
RANTES/US28 activation of FAK. Importantly, overexpression
of Gaq blocked RANTES signaling to FAK but had no effect on
Fractalkine-mediated FAK activation. In a number of different
activation scenarios FAK is a known point of signaling
convergence and has been demonstrated to be phosphorylated
in response to Gaq/11, Gai/o, and Ga12/13 coupled receptors in
various cell types and signaling environments [32–35]. In one
study, lysophosphatidic acid (LPA) signaling stimulated both
membrane association and autophosphorylation of FAK but these
two effects were separable and mediated by different G-alpha
subunits (Gai1 and Ga12/13, respectively) presumably via
signaling from two different LPA receptors [33]. Importantly, in
a receptor-decoupled system of constitutively active G-alpha
subunits, significant FAK phosphorylation can be observed via
signaling through Gaq, Ga12 and Ga13 [35]. These results are
consistent with our observations that both RANTES and
Fractalkine binding to US28 can activate FAK via different
signaling cascades mediated by different G-proteins. Our results
suggest that overexpression of off-target G-proteins inhibit
signaling from a particular ligand via competition with the G-
proteins that would normally promote signaling from the ligand-
bound activated receptor. Therefore, in these experiments
overexpression of Ga12 may act as a dominant inhibitory
molecule that prevents Gaq-receptor interactions, which would
normally activate FAK following Fractalkine coupling to US28.
Overexpression of Gaq prevents Ga12 coupling to the RANTES-
bound activated form of US28 thereby abrogating the downstream
signaling to FAK. Therefore, RANTES stimulates varying
signaling pathways through different G-proteins in SMC (Ga12-
dependent) and fibroblasts (Gai/o independent). Fractalkine
signals from US28 via coupling of Gaq in fibroblasts, SMC and
macrophages. Together these findings demonstrate that not only is
US28 signaling ligand-dependent and ligand-specific, it utilizes
differential G-protein coupling to produce cell-type specific
signaling and differential phenotypic responses.
In this report, we demonstrate that similar to RANTES and
MCP-1, Fractalkine is a potent US28 agonist that promotes
migration in macrophages, robust signaling through FAK and
independent experiments. Percentages are calculated relative to unstimulated macrophages infected with Ad-Trans. Inset is the western blot
showing equal expression of US28-WT and Y16F in macrophages used for this migration assay.
doi:10.1371/journal.ppat.1000304.g005
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ERK1/2 and induces actin cytoskeletal rearrangements in
fibroblasts. Unlike RANTES and MCP-1, Fractalkine fails to
induce SMC migration, or increase expression of cellular genes
involved in motility and signaling in SMC, thus demonstrating
that US28 signaling is ligand-specific and cell type-specific. In
addition, the US28 ligand-specific and cell-type dependent
activation of differential signaling pathways suggest that this
chemokine receptor has the capacity to couple to different G-
proteins depending upon the ligand bound and the cellular G-
protein environment. Therefore, US28 binds to a diversity of
chemokines, which promote US28 coupling to multiple G-
proteins, eliciting functional signaling through these various G-
proteins. HCMV encounters and infects a multitude of distinct cell
types in vivo including fibroblasts, monocyte/macrophages, endo-
thelial cells and SMC. These cell types differ substantially with
respect to the G-proteins that they express. The ability of US28 to
respond to multiple signaling environments and couple to multiple
G-proteins may have important implications in the persistence and
pathogenesis of HCMV in these different cell-types.
Materials and Methods
Cell Lines
The life-extended human pulmonary artery smooth muscle cell
line, PAT1 [15] were maintained in Medium 199 supplemented
with 20% fetal calf serum (FCS) and penicillin-streptomycin-L-
glutamine (PSG; Gibco). For migration and microarray experi-
ments, PAT1 cells were utilized between passage 5 and 30 post-
telomerization. Primary F344 rat smooth muscle cells (RSMC)
were maintained in Dulbecco’s modified Eagle’s Medium
(DMEM) with 10% FCS and PSG. RSMC were used between
passage 5 and 20. NR8383 rat alveolar macrophages were
maintained in RPMI with 10% FCS and PSG. Mouse FAK2/
2 fibroblasts were maintained on gelatin coated culture dishes in
DMEM supplemented with 10% FCS, PSG, non-essential amino
acids (Cellgro), and G418 (Sigma; 500 mg/ml) as previously
described [36,37]. FAK2/2 cells used in experiments were
between passage 5 and 15.
Reagents
Recombinant human RANTES, MCP-1, and Fractalkine were
purchased from R&D Systems. Anti-Grb2 (C-7), anti-phosphotyr-
osine (PY99), anti-Ga12 (S-20), anti-Gaq (E-17) and anti-HA (F-7)
antibodies were purchased from Santa Cruz Biotechnology.
Phospho-specific ERK-1/2 (Thr202/Tyr204) and total ERK-1/
2 antibodies were from Cell Signaling Technologies. Anti-M2-Flag
antibody (F-3165) was purchased from Sigma. Secondary anti-
mouse and anti-rabbit horseradish peroxidase (HRP)-conjugated
antibodies (NA934V and NA931V) were purchased from
Amersham.
Adenovirus Construction
Adenoviruses expressing Ga12 Gaq, WT-FAK, US28-Flag,
and US28-HA were previously described [14–16]. Adenovirus
vectors expressing US28-Y16F-HA were constructed by muta-
genesis of the US28-HA construct in pAdTet7. This vector
contains the tet-responsive enhancer within a minimal CMV
promoter followed by the SV40 late poly(A) cassette, adenovirus
E1A, and a single loxP site to increase recombination frequency.
Complementary 30bp primers containing coding sequence for
amino-acids 2–25 of US28-HA and including a phenylalanine
codon in place of the tyrosine at position 16 (59-ACGACG-
GAGTTTGACTTCGACGATGAAGCG-39 and 59-
CGCTTCATCGTCGAAGTCAAACTCCGTCGT-39) were
used to PCR amplify mutated vector using Pfu Turbo DNA
Polymerase (Stratagene). Non-mutated methylated parental DNA
was digested using DpnI and mutated plasmid was propagated in
DH5a. Recombinant adenoviruses were produced by pAdTet7
US28-Y16F-HA construct co-transfection of 293 cells expressing
the Cre-recombinase with adenovirus DNA (Ad5-y5) that
contains an E1A/E3-deleted adenovirus genome [38]. Recombi-
nant adenoviruses were expanded on 293-Cre cells and the bulk
stocks were titered on 293 cells by limiting dilution. Gene
expression was driven by co-infection with Ad-Trans expressing
the Tet-off transactivator as previously described [14].
Flow Cytometry
To monitor surface expression of recombinant proteins and
total adenovirus transduction, adenovirus-infected cells were fixed
in 2% PFA for 15min, washed 26with PBS, blocked for 15min on
ice in Fc Block (PBS+20%Normal goat serum (NGS)+0.1%
sodium azide). To determine the rate of adenovirus transduction,
cells were permeablized with PBS containing 0.2% Saponin and
0.02%NGS for 15min on ice. For both cell surface and
intracellular staining assays the cells were incubated for 30min
with either mouse IgG2b isotype control or primary aHA
antibody diluted 1:200 in FACS wash buffer (PBS+1%
NGS+0.01% sodium azide +/2 0.2% saponin as appropriate)
on ice and washed 26with FACS wash buffer. Primary antibody
staining was detected with anti-mouse Alexa-Fluor597 antibody
diluted 1:1000 in FACS wash. After 20 min incubation with
secondary antibody on ice cells were washed as above and surface
expression was quantified using flow cytometry (FACS Calibur,
BD Biosystems). Data analysis was performed using FlowJo
software v8.8 (Treestar Inc.).
Immunocytochemistry
FAK2/2 fibroblasts were grown in 0.1% gelatin coated 4-well
chamber slides (Nalge-Nunc). US28 and/or FAK was expressed
using the adenovirus vectors described above and were left
untreated or were treated with MCP-1, RANTES or Fractalkine
(20ng/ml) for 2 hrs. The cells were washed in PBS and fixed in
phosphate buffered 2% paraformaldehyde (PFA) for 15 minutes at
r.t., then permeabilized and blocked with 0.2% Saponin+0.02%
BSA in PBS for 15min at r.t. Thereafter, the cells were incubated
with antibodies against US28-Flag epitope or FAK-HA epitope in
a 1:200 dilution for 1 hr at room temperature. Cells were washed
three times in blocking buffer and binding of the primary antibody
was detected with a fluorescein isothiocyanate-tetramethyl (FITC)
conjugated goat anti-mouse or rhodamine conjugated goat anti-
rabbit antibody for 1 hr at room temperature. At this time the cells
were also stained for actin using Phalloidin (Molecular Probes,
Eugene, OR) to monitor alterations in cellular actin cytoskeleton
induced by US28 and FAK. Fluorescence positive cells were
visualized on an inverted Applied Precision DeltavisionTM
deconvolution microscope.
Immunoprecipitation Reactions
FAK2/2 cells were plated in 10cm culture dishes and serum
starved for 6 hrs upon achieving 50% confluence. The cells were
co-infected with Ad-Trans and/or Ad-US28 and/or Ad-FAK WT
at MOI 50. After 16 hrs the cells were stimulated with RANTES
(40ng/ml), Fractalkine (40ng/ml), or MCP-1 (40ng/ml) and then
harvested at times 0 (unstimulated), 5, 10, 15, and 30 minutes post
ligand addition. Cells were lysed in modified RIPA buffer
containing 1% Triton X-100, 1% sodium deoxycholate, and
0.1% SDS and total Grb2 was immunoprecipitated and samples
analyzed by western blotting using antibodies directed against
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phospho-Tyr [16]. Co-precipitation of FAK-HA was demonstrat-
ed by stripping the blots in buffer containing 0.1M Tris pH 6.8,
1% SDS, and 1% 2-mercaptoethanol and staining using
antibodies directed against HA. Prior to immune-complex
reactions, a total of 50 ml of cellular lysate was assayed by SDS-
PAGE/western blotting for the presence of input US28 and FAK
using antibodies directed against the HA-epitope present on both
recombinant proteins.
SMC Migration Assay
SMC migration assays were performed as previously described
[14]. Briefly, 46104 primary rat SMCs were added to each upper
well of a transwell (12 mm diameter, 3.0 mm pore size, Costar
Corning, Cambridge, MA). Cells were serum starved for 16 hrs,
and then infected with Ad-Trans only or Ad-Trans and Ad-US28-
HA at MOI 200. After 4 hrs, the inserts were washed and
transferred to fresh 12-well plates with chemotactic stimulus. Cells
migrating to the lower chamber were quantified at 48–72 hrs p.i.
via fluorescence using CyQuant (Invitrogen) and read on a
Molecular Devices FlexstationH II fluorescence plate reader.
Migration was determined from 4–6 independent wells per assay
per condition. Mean and standard deviation were calculated.
Percent of control values were generated by comparing chemokine
stimulated US28-expressing cells to unstimulated control cells
(Trans-only) and compared using Student’s t test. P values,0.05
were considered statistically significant.
Macrophage Migration Assay
NR8383 macrophages were co-infected with Ad-Trans and Ad-
US28 WT or Ad-US28-Y16F at MOI 100. Macrophages were
incubated with adenovirus in 200 ml total volume for 30min at
room temperature, diluted into 10ml complete RPMI and
incubated at 37uC. At 72 hrs post-infection, 16105 infected
macrophages were added to the top well of a chemotaxis chamber
(96-well Millipore Multiscreen, 3.0 mm pore size) with Fractalkine
and/or human RANTES in the bottom chamber. Chemotaxis
was allowed to proceed for 1 hr at 37uC. Top chambers were
discarded and migrated cells in the bottom chamber were
quantified via fluorescence using CyQuant (Invitrogen) and read
on a Molecular Devices Flexstation II fluorescence plate reader.
Migration was determined from 4–6 independent wells per assay
per condition. Mean and standard deviation were calculated.
Percent of control values were generated by comparing chemokine
stimulated US28-expressing cells to unstimulated control cells
(Trans-only) and compared using Student’s t test. P values,0.05
were considered statistically significant. Recombinant protein
levels were monitored by western blotting and flow cytometry
staining for total and surface expression and equalized by adjusting
the adenoviral vector MOI accordingly.
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